Back to Renaissance Technologies LLC Renaissance Technologies LLC

CLDX

21 quarters

Position history for Renaissance Technologies LLCRenaissance Technologies LLC's holdings in Celldex Therapeutics, Inc.

No. Renaissance Technologies exited its CLDX (Celldex Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 118,488 shares worth $3.2M. Renaissance Technologies already held CLDX in its Q3 2019 13F, the earliest on record, and held it in 17 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.2M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$31.72
0
2025-Q4
Decreased
118,488
-39.1%
$3.2M0.0%$27.16
0
2025-Q3
Increased
194,588
+7.3%
$5M0.0%$25.87
29
2025-Q2
Increased
181,388
+23.7%
$3.7M0.0%$20.35
32
2025-Q1
Increased
146,588
+7.3%
$2.7M0.0%$18.15
28
2024-Q4
New
136,588
-
$3.5M0.0%$25.27
37
2024-Q3
Exited
0
-100.0%
$00.0%$33.99
0
2024-Q2
Decreased
42,788
-86.3%
$1.6M0.0%$37.01
0
2024-Q1
New
312,470
-
$13.1M0.0%$41.97
39
2022-Q4
Exited
0
-100.0%
$00.0%$44.57
0
2022-Q3
New
25,888
-
$728,0000.0%$28.11
34
2021-Q4
Exited
0
-100.0%
$00.0%$38.64
0
2021-Q3
Decreased
161,276
-55.7%
$8.7M0.0%$53.99
0
2021-Q2
Decreased
364,027
-32.8%
$12.2M0.0%$33.44
0
2021-Q1
Decreased
541,427
-48.4%
$11.2M0.0%$20.60
0
2020-Q4
Decreased
1M
-39.6%
$18.4M0.0%$17.52
0
2020-Q3
Increased
1.7M
+6.1%
$25.8M0.0%$14.83
30
2020-Q2
Increased
1.6M
+39.9%
$21.3M0.0%$13.00
38
2020-Q1
Increased
1.2M
+4.9%
$1.9M0.0%$1.66
27
2019-Q4
Increased
1.1M
+8.7%
$2.5M0.0%$2.23
28
2019-Q3
First report
1M
-
$2.2M0.0%$2.13
0

Other major holders of CLDX: FMR LLC, Wellington Management Group LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used